Status | Study |
Recruiting |
Study Name: Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis Condition: Lymphangioleiomyomatosis Date: 2013-02-23 Interventions: Drug: albuterol inhaler Procedure: PFT |
Completed |
Study Name: Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis Condition: Lymphangioleiomyomatosis Date: 2012-08-02 Interventions: Drug: sirolimus and hydroxychloroquine This will be a phase I dose escalation study of the combination o |
Recruiting |
Study Name: National Lymphangioleiomyomatosis Registry, France Condition: Lymphangioleiomyomatosis Date: 2011-11-30 |
Completed |
Study Name: Trial of Aromatase Inhibition in Lymphangioleiomyomatosis Condition: Lymphangioleiomyomatosis Date: 2011-05-11 Interventions: Drug: Letrozole 2.5 mg daily f |
Completed |
Study Name: A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis Condition: Lymphangioleiomyomatosis Date: 2010-01-28 Interventions: Drug: Everolimus |
Completed |
Study Name: Doxycycline In Lymphangioleiomyomatosis (LAM) Condition: Lymphangioleiomyomatosis Tuberous Sclerosis Date: 2009-10-02 Interventions: Drug: Doxycycline 50mg od |
Completed |
Study Name: Pulmonary Hypertension in Lymphangioleiomyomatosis Condition: Lymphangioleiomyomatosis Pulmonary Hypertension Date: 2009-08-17 |
Completed |
Study Name: Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Condition: Tuberous Sclerosis Complex (TSC) Lymphangioleiomyomatosis (LAM) Date: 2008-11-10 Interventions: Drug: Everolimus (RAD001) Ever |
Completed |
Study Name: Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM Condition: Tuberous Sclerosis Lymphangioleiomyomatosis Date: 2007-06-21 Interventions: Drug: sirolimus daily oral sirolimus with dosage individualised by trough blood levels |
Completed |
Study Name: Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM Condition: Tuberous Sclerosis Lymphangioleiomyomatosis Date: 2007-04-06 Interventions: Drug: Rapamycin, sirolimus |